Letter from the Editor-in-Chief

Adam Chicheł

eISSN: 2081-2841
ISSN: 1689-832X

Journal of Contemporary Brachytherapy

Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links

Editorial System

Submit your Manuscript

1/2022
vol. 14

Send email

Copy url:

abstract:

Letter to the Editor

Letter from the Editor-in-Chief

Adam Chicheł

Online publish date: 2022/02/18

View full text Get citation

I gladly introduce the first issue of the “Journal of Contemporary Brachytherapy” this year. The 2022 year has just started, yet we face another COVID-19 high wave of infections. Whatever happens with the pandemic, we treat our patients with constantly high standards of care. Facing the problem, Yale University (USA) authors submitted their preliminary report. They verified a novel institutional approach during the COVID-19 pandemic: a single-application hybrid interstitial BT for cervical cancer. Local control outcomes demonstrated the regimen effective; however, the increased risk of mucosal toxicity need to be observed and monitored.